France pharmaceuticals & chemical past production (SA)
France pharmaceuticals & chemical past production (SA) stood at -4.3 Balance of opinion (%) in Sep 2026, according to INSEE – Institut national de la statistique et des études économiques (BDM). It is one of the indicators in the INSEE business surveys table (Value · Monthly), with a complete series running from Feb 1990 to Sep 2026. The complete series with an interactive chart, free to download.
This indicator in the INSEE business surveys table
| Indicator | 09-2026 | 08-2026 | 07-2026 | 06-2026 | 05-2026 | 04-2026 | 03-2026 | 02-2026 | 01-2026 | 12-2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Industry | |||||||||||
| Monthly business survey in goods-producing industries - Pharmaceuticals, medical chemical and botanical products - Past trend in production (balance of opinion) - SA series | -4.3 | 39.2 | 8.9 | 0.7 | 45 | 48.2 | 6.7 | 9.5 | -1.9 | 0.5 | |
| Monthly business survey in goods-producing industries - Manufacture of rubber and plastic and other non-metallic mineral products - Past trend in production (balance of opinion) - SA series | -14.8 | -10 | -10.3 | -5.4 | 5.6 | -1.6 | -18.9 | -20.3 | -15.4 | -14.3 |
Understanding france pharmaceuticals & chemical past production (SA)
Enterprise managers directing the fabrication of medicinal drugs, pharmaceutical preparations, and botanical products submit monthly assessments tracking historical output changes within the health-focused manufacturing segment. This data series isolates life-science chemistry from industrial and petrochemical manufacturing, providing a specialized view of healthcare product fabrication. It records whether factory throughput increased or decreased relative to previous months, covering active pharmaceutical ingredients and dosage formulations. Excluded are wholesale medical distribution, hospital services, and heavy industrial chemical synthesis.
Reading this healthcare manufacturing indicator requires noting that production schedules in this sector often follow long-term regulatory approvals and specialized clinical demand rather than standard macroeconomic cycles. Seasonal patterns are typically less pronounced here than in consumer goods or construction-linked industries, yet periodic maintenance shutdowns can still induce temporary survey dips. Analysts comparing this series to general chemical indices should account for the decoupled demand drivers, as medicinal product requirements respond to public health factors rather than industrial intermediate demand.
Frequently asked questions
- What distinct product groups are covered by this index?
- It tracks medicinal chemicals, basic pharmaceutical products, and finished pharmaceutical preparations.
- How does this differ from the general chemical industry series?
- This series focuses exclusively on health-related and botanical products, excluding industrial petrochemicals and fertilizers.
- Does this survey capture retail pharmacy sales?
- No, it is strictly a survey of manufacturing plant directors regarding factory output, omitting retail distribution.